Evidence map›Paper›PMID 26551777›Full record

Trial reportBone marrow transplantation2016

A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F.

S Fuji, S W Kim, S Yano, S Hagiwara, H Nakamae, M Hidaka, T Ito, K Ohashi, K Hatanaka, A Takami and 4 more

Abstract readClinical TrialLetter
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

S FujiDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
S W KimDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
S YanoDivision of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
S HagiwaraDivision of Hematology, National Medical Center for Global Health and Medicine, Tokyo, Japan.
H NakamaeDepartment of Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
M HidakaDepartment of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
T ItoDivision of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan.
K OhashiDivision of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
K HatanakaDepartment of Hematology/Oncology, Wakayama Medical University Hospital, Wakayama, Japan.
A TakamiDepartment of Hematology and Oncology, Kanazawa University Hospital, Kanazawa, Japan.
S KurosawaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
T YamashitaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
T YamaguchiDivision of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
T FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Jikei University School of Medicine · JPKanazawa University Hospital · JPKumamoto Medical Center · JPNational Center for Global Health and Medicine · JPOsaka City University · JPShinshu University · JPTohoku University · JPTokyo Metropolitan Komagome Hospital · JPWakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone Marrow TransplantationTransplantation ConditioningUnrelated DonorsAdultAgedAllograftsAntilymphocyte SerumBusulfanChronic DiseaseFemaleGraft vs Host DiseaseHematologic NeoplasmsHumansIncidenceMaleMiddle AgedAntilymphocyte SerumBusulfanfludarabineVidarabine

Identifiers

PMID26551777
OpenAlexW2322529643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.